Wedbush Comments on Passage Bio’s Q1 Earnings (NASDAQ:PASG)
Passage Bio, Inc. (NASDAQ:PASG – Free Report) – Equities research analysts at Wedbush lifted their Q1 2025 earnings per share (EPS) estimates for shares of Passage Bio in a research report issued on Tuesday, March 4th. Wedbush analyst Y. Zhong now expects that the company will earn ($0.23) per share for the quarter, up from […]
